These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20038781)

  • 1. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial: botulinum toxin for neuropathic pain?
    Torgovnick J; Arsura E; Sethi NK; Hu CJ; Yuan RY; Sheu JJ; Apfel SC
    Neurology; 2010 Jan; 74(1):92; author reply 92-3. PubMed ID: 20038781
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
    Yuan RY; Sheu JJ; Yu JM; Chen WT; Tseng IJ; Chang HH; Hu CJ
    Neurology; 2009 Apr; 72(17):1473-8. PubMed ID: 19246421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin in tension-type headache.
    Relja M; Telarović S
    J Neurol; 2004 Feb; 251 Suppl 1():I12-4. PubMed ID: 14991337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin for neuropathic pain?
    Apfel SC
    Neurology; 2009 Apr; 72(17):1456-7. PubMed ID: 19321845
    [No Abstract]   [Full Text] [Related]  

  • 6. [Botulinum toxin type A in the treatment of neuropathic pain in a case of postherpetic neuralgia].
    Ruiz Huete C; Bermejo P
    Neurologia; 2008 May; 23(4):259-62. PubMed ID: 18516748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
    Carroll A; Barnes M; Comiskey C
    Clin Rehabil; 2008 Jun; 22(6):513-9. PubMed ID: 18511531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study.
    Schulte-Mattler WJ; Krack P;
    Pain; 2004 May; 109(1-2):110-4. PubMed ID: 15082132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lidocaine tape (Penles) reduces the pain of botulinum toxin injection for Meige syndrome.
    Onguchi T; Takano Y; Dogru M; Ono M; Tsubota K
    Am J Ophthalmol; 2004 Oct; 138(4):654-5. PubMed ID: 15488799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial.
    Sahai A; Khan MS; Dasgupta P
    J Urol; 2007 Jun; 177(6):2231-6. PubMed ID: 17509328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, placebo-controlled, crossover clinical trial of super blue-green algae in patients with essential blepharospasm or Meige syndrome.
    Vitale S; Miller NR; Mejico LJ; Perry JD; Medura M; Freitag SK; Girkin C
    Am J Ophthalmol; 2004 Jul; 138(1):18-32. PubMed ID: 15234278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using botulinum toxin to treat diabetic foot pain.
    Kaufman JL; Karceski S
    Neurology; 2009 Apr; 72(17):e82-5. PubMed ID: 19398700
    [No Abstract]   [Full Text] [Related]  

  • 14. Botulinum toxin A for the treatment of delayed gastric emptying.
    Friedenberg FK; Palit A; Parkman HP; Hanlon A; Nelson DB
    Am J Gastroenterol; 2008 Feb; 103(2):416-23. PubMed ID: 18070232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A (BOTOX) for treatment of migraine.
    Binder WJ; Brin MF; Blitzer A; Pogoda JM
    Semin Cutan Med Surg; 2001 Jun; 20(2):93-100. PubMed ID: 11474749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does duloxetine safely and effectively reduce the severity of diabetic peripheral neuropathic pain?
    Russell JW
    Nat Clin Pract Neurol; 2006 Jan; 2(1):18-9. PubMed ID: 16932514
    [No Abstract]   [Full Text] [Related]  

  • 17. Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse.
    Freitag FG; Diamond S; Diamond M; Urban G
    Headache; 2008 Feb; 48(2):201-9. PubMed ID: 18042229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
    Truong D; Duane DD; Jankovic J; Singer C; Seeberger LC; Comella CL; Lew MF; Rodnitzky RL; Danisi FO; Sutton JP; Charles PD; Hauser RA; Sheean GL
    Mov Disord; 2005 Jul; 20(7):783-91. PubMed ID: 15736159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin a treatment in chronic daily headache.
    Cutrer FM
    Headache; 2005 Apr; 45(4):270-1. PubMed ID: 15836560
    [No Abstract]   [Full Text] [Related]  

  • 20. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.